Estonia-based Better Medicine raises nearly $7 million to expand its radiology AI solution and enter the U.S. market.
Key Details
- 1Better Medicine is an AI startup focused on radiology, founded in 2020 in Estonia.
- 2The company raised an additional $1.2 million, bringing total funding close to $7 million.
- 3Its flagship product, BMVision Kidney, detects malignant lesions from CT scans.
- 4Better Medicine currently operates in six countries and aims to expand to the U.S.
- 5The new funding will support further European growth and preparations for U.S. market entry.
Why It Matters
Better Medicine's growth and international expansion reflect ongoing investor confidence in radiology AI. Tools that integrate into radiologist workflows and target specific organs, such as the kidney, could enhance cancer detection and address radiologist shortages globally.
Source
Radiology Business
Related News
•AuntMinnie
ChatGPT-4 Turbo Powers Postdeployment Monitoring of ICH Detection AI
Researchers found ChatGPT-4 Turbo could efficiently monitor the performance of Aidoc's ICH detection AI across real-world radiology practices.
•Health Imaging
AI-Powered Ultrasound Tool Predicts Delivery Timing for Pregnant Patients
Researchers have created an AI model using ultrasound to accurately forecast expectant mothers’ delivery timelines.
•Radiology Business
Heartflow Raises $364M in Highly Subscribed Public Offering
Cardiac imaging AI company Heartflow raised $364 million from an upsized public stock offering, far exceeding expectations.